Vijaya Diagnostic CentreQ4 FY24

Vijaya Diagnostic Centre Q4 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,467.4P/E: 74.2Market Cap: ₹15.1K CrSector: Healthcare Services

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

No

Order

Yes

Capex

Yes

2 of 5 growth signals are positive.

Full analysis

Revenue guidance

Category 3
  • Company expects low single-digit volume growth (around 10-12%) in existing hubs limited by capacity constraints.
  • New hubs opening expected to drive faster growth with potential for low double-digit revenue growth once new capacity is added.
  • PH Pune business expected to triple revenue in 4-5 years, with 5 new hubs starting over 2 years.
  • Organic revenue growth excluding PH Pune around 18.5% year-on-year reported, driven primarily by volume growth (~17%).
  • Hyderabad core region showing healthy double-digit growth (~13-14%) in revenue and 11-12% in volume.
  • Tier 2 and new geographies showing higher volume growth, around 30-40%, due to capacity expansion.
  • Plans to add around 10 hubs in 2 years, with 4-5 in Pune for faster-market growth.
  • Overall revenue growth driven both by footfall increases and modest price/mix changes (1-2%).

See what Vijaya Diagnostic Centre management said on margin guidance — free account, 30 seconds.

Fundraise plans

No
  • No current need for raising debt as the company has a healthy treasury of around INR185 crore.
  • Expected free cash flow of INR170-190 crores annually supports upcoming capex requirements.
  • Planned capex of INR200-220 crores for new centers in the next 2 years will be funded largely through internal accruals and cash reserves.
  • Debt raising will only be considered if inorganic acquisitions are made, but no such plans currently.
  • Equity fundraising is not mentioned as a requirement currently.
  • Management emphasizes operational scaling and talent acquisition as key constraints rather than capital availability.

See what Vijaya Diagnostic Centre management said on order book — free account, 30 seconds.

Capex plans

Yes
  • Planned capital expenditure (capex) of INR 200 to 220 crores over the next 2 years.
  • Majority of capex aimed at adding about 10 new hubs, with 4 to 5 in Pune and the rest in eastern and core geographies.
  • INR 120 crores of the capex expected to be spent in the Pune region, including one flagship hub with PET CT, gamma camera, and state-of-the-art facilities.
  • Additional investment planned for adding spokes linked to these hubs, supporting network expansion.
  • Some capex reserved for adding new modalities and replacing old equipment (replacement capex of around INR 10-15 crores, over and above INR 220 crores).
  • Investments include upgrading IT systems and digital initiatives (~INR 2-3 crores annually).
  • Growth-funded primarily from internal accruals and existing cash reserves; no anticipated debt raising required.
  • Potential inorganic acquisitions considered if suitable opportunities arise.

Track Vijaya Diagnostic Centre — get its next earnings analysis in your feed

How does Vijaya Diagnostic Centre rank vs peers in Healthcare Services?

Pro feature
ThisVijaya Diagnostic Centre
Rev 3Mar 3

How does Vijaya Diagnostic Centre rank in Healthcare Services?

Compare Vijaya Diagnostic Centre against every Healthcare Services company (Q4 FY24) on revenue, margins and earnings-call signals.

View Healthcare Services leaderboard →

Others in Healthcare Services this season

  • Chandan Healthca (Q2 FY27)

    Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor

  • Invicta Diagnostic (Q2 FY27)

    Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2

  • Unihealth Hosp (Q2 FY27)

    1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r

  • Sangani Hospital (Q2 FY27)

    1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →